Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial quorum sensing (QS) and motility pathways are complex regulatory networks that enable bacteria to coordinate collective behaviors, such as virulence factor production and biofilm formation, in response to population density [1.1.3, 1.2.1]. These systems rely on the synthesis and detection of signaling molecules called autoinducers, including N-acyl homoserine lactones (AHLs) in Gram-negative bacteria and autoinducing peptides (AIPs) in Gram-positive species [1.1.1, 1.2.1]. Motility pathways, including swarming and twitching, are often co-regulated by QS to facilitate colonization and spread within a host [1.3.2, 1.4.2]. Targeting these pathways is a key 'anti-virulence' strategy aimed at disarming pathogens without directly killing them, thereby reducing the selective pressure for antibiotic resistance [1.3.1, 1.4.2]. Various drugs, including sub-inhibitory concentrations of macrolides like azithromycin and repurposed agents such as piroxicam, have been shown to disrupt these pathways by inhibiting signal synthesis, reception, or downstream gene expression [1.3.4, 1.3.5]. The molecular components of these pathways include autoinducer synthases (e.g., LuxI homologs), receptors (e.g., LuxR homologs like LasR and RhlR), and enzymes involved in signal metabolism like 5'-methylthioadenosine nucleosidase (MTAN) [1.1.3, 1.2.2]. Inhibition can be achieved through small molecules that compete with autoinducers for receptor binding or by 'quorum quenching' enzymes that degrade the signals [1.1.4, 1.3.3]. While these pathways are not essential for basic bacterial growth, they are critical for pathogenesis, making them attractive targets for treating chronic and multi-drug resistant infections [1.2.3, 1.3.2]. However, challenges remain regarding the potential for off-target effects on host signaling and the need for effective delivery into dense biofilm structures [1.2.1, 1.4.2].
Inhibition of autoinducer synthesis, competitive inhibition of signal receptors, enzymatic degradation of signaling molecules (quorum quenching), and interference with downstream gene transcription.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial quorum sensing and motility pathways (QS/Motility).